制药公司应该生产高品质的无专利通用药品，以减轻病人家庭的经济负担。
And that pharmaceutical companies should create high-quality generic drugs that won't break a family's budget.
工业专家维伦梅塔表示，无专利保护制药公司制造生物仿制药品将会比制造传统的无专利保护药品更有优势。
Generics firms will do better with biosimilars than they have with conventional generic drugs, insists Viren Mehta, an industry expert.
拥有互补性专利的双寡头厂商可以进行三种方式的专利交易，分别是无专利授权、交叉许可授权和专利联盟授权。
Two duopoly firms with the perfect complementary patents may conduct three types of patent transaction, they are no patent licensing, cross licensing, patent pools licensing respectively.
应用推荐